Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income (Loss) $ (420,279) $ (715,165)
Adjustments to reconcile net income (loss) to net cash provided by (used by) operating activities:    
Depreciation and amortization 20,762 15,706
Loss on equipment disposal 2,738 0
Bad debt expense 63,529 38,284
Amortization of discount on investment in account receivable (79,156) (91,375)
Investment interest income 1,678 (2,281)
(Gain) loss on investment in securities, at fair value 62,322 163,445
(Gain) loss on long-term investments (86,307) 0
Decrease (increase) in operating assets    
Cash in attorney trust account 314,536 (314,536)
Finance leases receivable (334,482) 0
Accounts receivable - trade (56,239) (101,678)
Receivable - Bhang Corporation 0 (487,099)
Prepaid expenses and other current assets (33,522) (1,249)
Employee advances 9,679 (12,983)
Increase (decrease) in operating liabilities    
Accounts payable 7,195 34,688
Accrued expenses 134,647 59,947
Deferred revenue 86,461 0
Accrued salary, retirement and benefits - related party 57,637 (68,897)
Net cash provided by (used by) operating activities (248,801) (1,483,193)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from receivable - Bhang Corporation 1,987,099 0
Purchase of investment securities (236,272) (1,071,901)
Proceeds from securities sold 0 754,643
Purchase of convertible notes receivable (50,000) (125,000)
Proceeds from convertible notes receivable 27,561 9,269
Advances on notes receivable (179,000) (900,000)
Proceeds from notes receivable 34,844 18,979
Deposits on equipment to be leased (43,907) 0
Investment in direct financing leases (1,202,799) 0
Purchase of contractual interest in legal recovery (200,000) 0
Purchases of property and equipment (25,740) (20,437)
Proceeds from sale of investment in Brighter Day Health 109,000 0
Purchase of long-term investments (15,669) 0
Proceeds from investment in receivable 117,000 0
Net cash provided by (used by) investing activities 322,117 (1,334,447)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Warrants converted to common stock, net of costs 629,205 2,395,105
Payments to rescind Bhang owners' common stock (228,150) 0
Issuance of Series Q preferred shares, net of costs 109,985 0
Short term loan from related parties 40,000 0
Proceeds from long-term debt 50,000 0
Payments on long-term debt (34,438) (34,833)
Non-controlling interest distribution (3,534) (19,780)
Net cash provided by (used by) financing activities 563,068 2,340,492
Net change in cash 636,384 (477,148)
Beginning cash 834,190 1,311,338
Ending cash 1,470,574 834,190
SUPPLEMENTARY INFORMATION:    
Cash paid for interest 17,451 3,251
Cash paid for income taxes 20,220 11,530
NON-CASH INVESTING AND FINANCING TRANSACTION:    
Shareholder assumption of warrant liability resulting in increased liability to shareholder (15,276) (92,054)
Contractual interest in legal recovery purchased through issuance of 288,890 shares of restricted common stock in private offerings $ 0 $ 600,002